&lt;i&gt;&lt;b&gt;Teplizumab&lt;/b&gt;&lt;/i&gt;&lt;i&gt;&lt;b&gt;, A Disease-Modifying Therapy for Type 1 Diabetes That &lt;/b&gt;&lt;/i&gt;&lt;i&gt;&lt;b&gt;Preserves Beta Cell Function&lt;/b&gt;&lt;/i&gt;

Eleanor L Ramos,Kevan C Herold,Laura A Knecht,Peter A Gottlieb,Ralph Raymond,Stephen E Gitelman

doi:10.2337/figshare.23802516

Teplizumab, A Disease-Modifying Therapy for Type 1 Diabetes That Preserves Beta Cell Function

Eleanor L Ramos, Kevan C Herold + Show 4 more

Open Access

https://doi.org/10.2337/figshare.23802516

Copy DOI

Publication Date: Aug 22, 2023

License type: cc-by-nc-sa

#Preservation Of Beta Cell Function #Self-limited Adverse Events + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Teplizumab, A Disease-Modifying Therapy for Type 1 Diabetes That Preserves Beta Cell Function

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.